Breast cancer is a heterogeneous disease, with recent advances in genomic analysis allowing greater resolution of molecularly discrete subtypes.9–11 While breast cancer has been conventionally divided into subtypes based on histological findings, including cell origin, ER, PR and HER2 receptor status, significant heterogeneity in prognosis and treatment outcomes has been observed. Here, PGR is linked to breast cancer.